CANCER PREVENTION AND CONTROL

COLLOQUIUM

Evaluating Molecular Markers for Cancer Diagnosis and Prognosis        David F. Ransohoff, MD   Speaker Dr. Ransohoff is Professor of Medicine, Director of Clinical Research Curriculum at the University of North Carolina Chapel Hill in Chapel Hill, North Carolina. Also, he is working on evaluating molecular markers for cancer with the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Learning Objective To understand "rules of evidence" for evaluating molecular markers for diagnosis and prognosis and to understand current proteomics and genomics research controversies in light of those rules. Target Audience Researchers and clinicians actively involved in topics that relate to cancer prevention and control Date/Time/Place Wednesday, March 9, 2005, 11:00 am Executive Plaza North Conference Room G 6130 Executive Boulevard Rockville, Maryland For Additional Information Office of Preventive Oncology 301-496-8640  If you are a person with a disability and require any assistive device, services or other reasonable accommodations to participate in this activity, please contact the Office of Preventive Oncology at 301-496-8640 at least one week in advance of the lecture date to discuss your accommodations needs.

The National Institutes of Health/Foundation for Advanced Education in the Sciences is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.